Adma Biologics (ADMA) Goodwill (2017 - 2025)

Adma Biologics has reported Goodwill for 9 years, with the latest figure at $3.5 million in Q4 2025.

• For the quarter ending Q4 2025, Goodwill changed 0.0% year-over-year to $3.5 million; the trailing twelve-month figure through Dec 2025 stood at $3.5 million (changed 0.0% YoY), and the FY2025 full-year result was $3.5 million, changed 0.0% from the prior year.
• Goodwill for Q4 2025 stood at $3.5 million, down from $3.5 million in the prior quarter.
• The five-year high for Goodwill was $3.5 million in Q4 2022, with the low at $3.5 million in Q3 2021.
• Historically, Goodwill has averaged $3.5 million across 5 years, with a median of $3.5 million in 2021.
• Annual changes were most pronounced in 2023 — Goodwill retreated 0.85% — and 2025, when it increased 0.86%.
• Adma Biologics' Goodwill stood at $3.5 million in 2021, then gained by 0.01% to $3.5 million in 2022, then fell by 0.85% to $3.5 million in 2023, then changed by 0.0% to $3.5 million in 2024, then changed by 0.0% to $3.5 million in 2025.
• The last three Goodwill figures came in at $3.5 million (Q4 2025), $3.5 million (Q3 2025), and $3.5 million (Q2 2025), per Business Quant data.